TradeWell Securities’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.53M Buy
10,052
+412
+4% +$88.6K 0.9% 17
2026
Q1
$2.1M Buy
9,640
+44
+0.5% +$9.76K 0.88% 17
2025
Q4
$2.19M Buy
9,596
+788
+9% +$180K 0.85% 18
2025
Q3
$2.15M Buy
8,808
+438
+5% +$89.2K 0.9% 17
2025
Q2
$1.55M Buy
8,370
+1,775
+27% +$330K 0.74% 18
2025
Q1
$1.38M Sell
6,595
-9
-0.1% -$1.75K 0.76% 17
2024
Q4
$1.17M Buy
+6,604
New +$1.21M 0.61% 18

Other funds holding ABBV

TradeWell Securities's ABBV Position: Q2 2026 in Review

TradeWell Securities increased its AbbVie (ABBV) stake by 4.3% in Q2 2026, buying an estimated $88.6K and bringing the position to 10,052 shares worth $2.53M. The position accounts for 0.9% of the portfolio, ranked #17.

TradeWell Securities first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 2,141 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • TradeWell Securities held 10,052 shares of AbbVie worth $2.53M as of Q2 2026.
  • TradeWell Securities bought 412 AbbVie shares in Q2 2026, an estimated $88.6K.
  • AbbVie made up 0.9% of TradeWell Securities's portfolio in Q2 2026, its #17 holding.
  • TradeWell Securities first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 2,141 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on TradeWell Securities's 13F filing for Q2 2026, filed 28 Jul 2026.